-
RWE FOR SINGLE AND WELL-CONTROLLED STUDIES: AN EVALUATION OF FDA SUBMISSIONS FOR EFFECTIVENESS
Feb 25, 2026, 14:41 PM -
THIRTY YEARS OF THE ECHO MODEL: A BIBLIOMETRIC ANALYSIS OF ITS GLOBAL INFLUENCE ON HEALTH ECONOMICS AND OUTCOMES RESEARCH
Feb 25, 2026, 14:41 PM -
INSIGHTS INTO RANGE OF MOTION (ROM) AND PHYSICAL FUNCTION (PF) CHANGES EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: RESULTS FROM EXIT INTERVIEWS
Feb 25, 2026, 14:41 PM -
ECONOMIC BURDEN OF LOWER EXTREMITY ENDOVASCULAR REINTERVENTION IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: A REAL-WORLD COST ANALYSIS
Feb 25, 2026, 14:41 PM -
A STUDY ON ASSESSMENT OF RISK FACTORS, COMPLICATIONS AND CLINICAL EFFICACY OF HEPATOPROTECTIVES IN LIVER DISEASE
Feb 25, 2026, 14:41 PM -
ASSOCIATIONS OF STRUCTURAL POSITION AND HIV TESTING WITH GUIDELINE-CONCORDANT CERVICAL CANCER SCREENING AMONG U.S. WOMEN AT HIGH RISK OF HIV INFECTION
Feb 25, 2026, 14:41 PM -
COST-UTILITY OF TENOFOVIR DISOPROXIL FUMARATE VERSUS ENTECAVIR FOR CHRONIC HEPATITIS B IN INDIA: A MARKOV STATE-TRANSITION MODEL
Feb 25, 2026, 14:41 PM -
QUALITY OF LIFE IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER: AN IRONMAN REGISTRY ANALYSIS
Feb 25, 2026, 14:41 PM -
PHARMACOECONOMIC EVALUATION OF DIFFERENT GONADOTROPIN-RELEASING HORMONE ANALOGS IN THE TREATMENT OF CHILDREN WITH CENTRAL PRECOCIOUS PUBERTY IN CHINA
Feb 25, 2026, 14:41 PM -
BEYOND QALYS: ALTERNATIVE COST-EFFECTIVENESS MEASURES IN ICER REPORTS FROM 2019 TO 2025
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS OF BIOLOGIC TREATMENTS IN ADULTS WITH SEVERE UNCONTROLLED EOSINOPHILIC ASTHMA: A U.S. PAYER PERSPECTIVE MARKOV MODEL
Feb 25, 2026, 14:41 PM -
A RETROSPECTIVE CROSS-SECTIONAL STUDY OF DRUG UTILIZATION EVALUATION OF ANTI-EPILEPTIC AGENTS IN A TERTIARY CARE HOSPITAL
Feb 25, 2026, 14:41 PM -
DEVELOPMENT AND EVALUATION OF CELLS, AN ENSEMBLE OF OPEN-WEIGHT LARGE LANGUAGE MODELS FOR SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:41 PM -
A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE
Feb 25, 2026, 14:41 PM -
THE FEASIBILITY OF MEASURING BTKI MEDICATION ADHERENCE IN THE TREATMENT OF CLL/SLL USING AN ELECTRONIC PATIENT-REPORTED OUTCOMES (EPRO) PLATFORM
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS ANALYSIS OF RELMACABTAGENE AUTOLEUCEL VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) WHO HAVE FAILED AT LEAST TWO LINES OF SYSTEMIC THERAPY IN CHINA
Feb 25, 2026, 14:41 PM -
COMPARATIVE ANALYSIS OF THE EPIDEMIOLOGICAL BURDEN OF STROKE IN EASTERN, CENTRAL AND WESTERN EUROPE BASED ON GLOBAL BURDEN OF DISEASE STUDY DATA
Feb 25, 2026, 14:41 PM -
TRENDS IN LDL CHOLESTEROL LEVELS AMONG MEDICARE ADVANTAGE BENEFICIARIES: 2015-2024
Feb 25, 2026, 14:41 PM -
COMPARING HTA DECISIONS, PRICING NEGOTIATIONS, AND REIMBURSEMENT OF INFLIXIMAB BIOLOGIC ORIGINATOR AND BIOSIMILARS IN CANADA
Feb 25, 2026, 14:41 PM -
APALUTAMIDE (APA) AS FIRST OPTION TO METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) REPRESENTS COST-EFFECTIVE TREATMENT SEQUENCES TO HEALTH SYSTEMS
Feb 25, 2026, 14:41 PM
